0001104659-13-085977.txt : 20131120
0001104659-13-085977.hdr.sgml : 20131120
20131120125415
ACCESSION NUMBER: 0001104659-13-085977
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130930
FILED AS OF DATE: 20131120
DATE AS OF CHANGE: 20131120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 VAUGHN DRIVE
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-945-6050
MAIL ADDRESS:
STREET 1: 5 VAUGHN DRIVE
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALAKATOS NICHOLAS
CENTRAL INDEX KEY: 0001252522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 131232329
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
a4.xml
4
X0306
4
2013-09-30
0
0001410939
Ophthotech Corp.
OPHT
0001252522
GALAKATOS NICHOLAS
C/O CLARUS VENTURES, LLC,
101 MAIN STREET, SUITE 1210
CAMBRIDGE
MA
02142
1
0
1
0
Common Stock
2013-09-30
4
P
0
2500
22
A
2500
D
Common Stock
2013-09-30
4
P
0
2500
22
A
2500
I
See Footnote
Common Stock
3054744
I
See Footnote
These shares are held by AAG Peakham Trust LLC. Dr. Galakatos is a manager of AAG Peakham Trust LLC.
Reflects 3,054,744 shares of Common Stock held of record by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLP disclaims beneficial ownership of all shares held of record by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which the GPLLC does not have an actual pecuniary interest.
Dr. Galakatos, together with other individuals identified in filings made by Clarus, each as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Dr. Galakatos disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest. The 3,054,744 shares of Common Stock held of record by Clarus constitute shares of Common Stock issued upon the conversion of preferred stock, including shares of preferred stock issued as accrued stock dividends, in connection with the closing of the issuer's initial public offering, which shares were previously reported on a Form 4 filed on October 2, 2013.
/s/ Nicholas Galakatos
2013-11-20